You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory pancreatic cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Tucson (Cabozantinib + Atezolizumab)

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Cabozantinib + Atezolizumab
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 14, 2022

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Metastatic Pancreatic Cancer Trial (Azeliragon)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • (no location specified)
Mar 10, 2023

Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

Not yet recruiting
  • Metastatic Cancer
  • +5 more
  • (no location specified)
Jul 10, 2023

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Recurrent Trial in Italy (Decitabine 50 MG [Dacogen])

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Pancreatic Adenocarcinoma Recurrent
  • Decitabine 50 MG [Dacogen]
  • Milano, Italy
  • +5 more
Jul 13, 2022

Advanced Pancreatic Cancer Trial in Nanjing (Adoptive TIL-TCM transfer therapy)

Recruiting
  • Advanced Pancreatic Cancer
  • Adoptive TIL-TCM transfer therapy
  • Nanjing, Jiangsu, China
    Jinling Hospital
Jun 29, 2022

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Advanced Pancreatic Carcinoma Trial in Shenzhen (CD276 CAR-T cells)

Recruiting
  • Advanced Pancreatic Carcinoma
  • CD276 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Dec 2, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +22 more
  • TRPV6 Calcium Channel Inhibitor SOR-C13
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Pancreas Cancer Trial in Hong Kong (TAS 102)

Recruiting
  • Pancreas Cancer
  • TAS 102
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, HKU
Jul 13, 2022

Solid Tumor, Lung Cancer, Colorectal Cancer Trial in Chongqing (CEA CAR-T cells)

Recruiting
  • Solid Tumor
  • +6 more
  • CEA CAR-T cells
  • Chongqing, Chongqing, China
  • +1 more
Sep 9, 2022

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Opioid-Related Disorders, Pain Management, Pain Management and Care Trial in Boston (Psilocybin)

Not yet recruiting
  • Opioid-Related Disorders
  • +4 more
  • Boston, Massachusetts
  • +2 more
Aug 14, 2023

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

Not yet recruiting
  • Cancer
  • +4 more
  • (no location specified)
Dec 15, 2022

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based

Active, not recruiting
  • Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
  • Irinotecan liposome、5-Fluorouracil、Leucovorin
  • Placebo、5-Fluorouracil、Leucovorin
  • Nanjing, Jiangsu, China
    Qinhuai Medical Area, General Hospital of PLA Eastern Theater Co
Sep 29, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022